Hypoglycemic and hypolipidemic effects of a triterpenoid-rich extract from Euryale shell on streptozotocin-induced diabetic mice

Pharmazie

Volumn 68, Issue 3, 2013, Pages 227-231

  Yuan, Huaibo ^a,b   Gong, Zhaobin ^a   Meng, Shaohua ^a   He, Guoqing ^b  

^a HEFEI UNIVERSITY OF TECHNOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; EURYALE FEROX EXTRACT; GLIMEPIRIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; TRIACYLGLYCEROL; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; EURYALE FEROX; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOGLYCEMIA; HYPOLIPEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIVER; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; ORGAN WEIGHT; SPLEEN; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MICE; ORGAN SIZE; PLANTS, MEDICINAL; SEEDS; TRITERPENES;

EID: 84874817042     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2734     Document Type: Article

References (28)

1. Bhaskar A, Vidhya VG, Ramya M (2008) Hypoglycemic effect of Mucuna pruriens seed extract on normal and streptozotocin-diabetic rats. Fitoterapia 79: 539-543.
2. Bailey LJ, Day C (1989) Traditional plant medicines as treatment for diabetes. Diab Care 12: 553-564.
3. Sharma B, Balomajumder C, Roy P (2008) Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol 46: 2376-2383.
4. Brennan CS, Cleary LJ (2005) The potential use of cereal beta-D-glucans as functional food ingredients. J Cereal Sci 42: 1-13.
5. De Fronzo RA, Bonadonna RC, et al. (1997) International Textbook of Diabetes Mellitus. Chichester: John Wiley & Son Ltd 1: 635-711.
6. Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, Parkes DG, Young AA (2005) Exenatide (exendin-4) improves insulin sensitivity and B-cell mass in insulin resistant obesefalfa Zucker rats independent of glycemia and body weight. Endocrinology 146: 2069-2070.
7. Gong H, NiY, Guo X, Fei L, PanX, Guo M, ChenR(2004) Resistin promotes 3T3-Ll preadipocyte differentiaion. Eur J Endocrinol 150: 885-892.
8. Huang THW, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y (2005) Anti-diabetic action of Punica granatum flower extract: activation of PPAR-c and identification of an active component. Toxicol Appl Pharmacol 207: 160-169.
9. Kim H, Stote KS, Behall KM, Spears K, Vinyard B, Conway JM (2009) Glucose and insulin responses to whole grain breakfasts varying in soluble fibre: A dose-response study in obese women with increased risk for insulin resistance. Eur J Clin Nutr 48: 170-175.
10. King H, Aubert RE, Herman WH (1998) Prevalence, numerical estimates, and projections. Diabetes Care 21: 1414.
11. Leahy JL (2005) Beta-cell dysfunction in type 2 diabetes melllitus. Joslin's Diabetes Mellitus. 14th ed. Philadelphia 1: 449-462.
12. Lee SE, Ju EM, Kim JH (2002) Antioxidant activity of extracts from Euryale ferox seed. Exp Mol Med 34: 100-106.
13. Maiti R, Das UK, Ghosh D (2005) Attenuation of hyperglycemia and hyperlipidemia in streptozotocin induced diabetic rats by aqueous extract of seed of Tarmarindus indica. Biol Pharm. Bull 28: 1172-1176.
14. Matveyenko AV, Butler PC (2008) Relationship between Beta-cell mass and diabetes onset. Dibetes, Obesity and Metab 10: 28-31.
15. Nath BK, Chakraborty AK (1985) Studies on amino acid composition of the seeds of Euryale ferox Salisb. Food Sci Technol 22: 293-296.
16. Oliveira ACP, Endringer DC, Amorim LAS, Brandão MGL, Coelho MM (2005) Effect of the extracts and fractions of Baccharis trimera and Syzygium cumini on glycemia of diabetic and non-diabetic mice. J Ethnopharmacol 102: 465-469.
17. Ono H, Katagiri H, Funaki M, Anai M, Inukai K, Fukushima Y, Sakoda H, Ogihara T, Onishi Y, Fujishiro M, Kikuchi M, Oka Y, Asano T (2001) Regulation of phosphoinositide metabolism, Akt phosphorylation and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome l0) in 3T3-Ll adipocytes. Mol Endocrino 15: 1411-1422.
18. RowLC, Ho JC, ChenCM(2007) Cerebrosides and tocopherol trimers from the seeds of Euryale ferox. J Nat Prod 70: 1214-1217.
19. Sharma SB, Nasir A, Prabhu KM, Dev G, Murthy PS (2003) Hypoglycemic and hypolipide-mic effect of ethanolic extracts of seeds of E. Jambolana in alloxan-induced diabetic model of rabbits. J. Ethnopharmacol 85: 201-206.
20. Song H, Shojima N, Sakoda H Ogihara T, Fujishiro M, Katagiri H, Anai M, Onishi Y, Ono H, Inukai K, Fukushima Y, Kikuchi M, Shimano H, Yamada N, OkaY, AsanoT(2002) Resistin is regulated by C/EBP, PPARs, and signal-transducing molecules. Biochem Biophys Res Commun 299: 291-298.
21. Tahrani AA, Piya MK, Kennedy A, Barnett AH (2010) Glycaemic control in type 2 diabetes: Targets and new therapies. Pharmacol Ther 125: 328-361.
22. Topping D (2007) Cereal complex carbohydrates and their contribution to human health. J Cereal Sci 46: 220-229.
23. Van De Laar FA, Lucassen PL, Akkermans RP, Van De Lisdonk EH, Rutten GE, Van WC (2005) Alpha-glucosidase inhibitors for patients with type 2 diabetes: Results from a cochrane systematic review and meta-analysis. Diabetes Care 28: 154-163.
24. Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin instreptozocin- induced diabetic rats. Comp Biochem Physiol Part C 135: 357-364.
25. Wood PJ (2007) Cereal beta-glucans in diet and health. J Cereal Sci 46: 230-238.
26. Yasuda K, Shimowada K, Uno M, Odaka H, Adachi T, Shuhara N (2003) Long-term therapeutic effects of voglibose, a potent intestinal alphaglucosidase inhibitor, in spontaneous diabetic GK rats. Diabetes Res Clin Pract 59: 113-122.
27. Yoshida T, Okuno A, Tanaka J, Takahashi K, Nakashima R, Kanda S, Ogawa J, Hagisawa Y, Fujiwara T (2009) Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilisation in a non-obese type 2 diabetes Goto-Kakizaki rats. Eur J Pharmacol 623: 141-147.
28. Zhao HR, Zhao SX, Guillaume D, Sun C (1994) New cerebrosides from Euryale ferox. J Nat Prod 57: 138-142.